Hi-TECH Beauty Labs Secures U.S. Patent for Skin Treatment Technology
Hi-TECH Beauty Labs has received U.S. Patent No. 12,642,834 B2 for its B3 Technology®, a 100% natural botanical innovation for problem skin. The company is seeking $5 million in seed funding.
Hi-TECH Beauty Labs, Corp. (HTBL) announced the issuance of U.S. Patent No. 12,642,834 B2 for its B3 Technology®. This 100% natural botanical innovation is designed to address problem skin without relying on ingredients like benzoyl peroxide, salicylic acid, adapalene, or retinol.
The technology platform merges high-tech principles from Silicon Valley with skin cell science and botanicals. Founder Matthew J. Schirle, a former semiconductor executive, applies engineering methodologies to skincare challenges, with Chief Science Officer Dr. D. William Provance as the inventor.
B3 Technology® utilizes ingredients such as Black Willow Bark, Cat's Claw, and Dragon's Blood within HTBL's proprietary SkinViNO™ Process. The company aims to provide an alternative to harsh, acid-based formulations and is exploring potential licensing opportunities with established beauty companies.
HTBL plans to present its commercialization strategy and seed capital opportunity at the Global Capital Network Investor Conference on October 15, 2026. The company is seeking $5 million in seed funding to accelerate its e-commerce, distribution, and technology commercialization efforts.